AD Pharma

Global Next Generation Cancer Diagnostics Market 2017 (Next Generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays and DNA Microarrays) : Global QYResearch

Press Release   •   Feb 15, 2017 10:15 EET

This report studies Global Next Generation Cancer Diagnostics Market 2017, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Next Generation Cancer Diagnostics in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India

Request more information at http://globalqyresearch.com/download-sample/163736 

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays

Split by application, this report focuses on consumption, market share and growth rate of Next Generation Cancer Diagnostics in each application, can be divided into
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others

View full report at http://globalqyresearch.com/global-next-generation-cancer-diagnostics-market-research-report-2017

Table of Contents

Global Next Generation Cancer Diagnostics Market Research Report 2017
1 Next Generation Cancer Diagnostics Market Overview
1.1 Product Overview and Scope of Next Generation Cancer Diagnostics
1.2 Next Generation Cancer Diagnostics Segment by Type
1.2.1 Global Production Market Share of Next Generation Cancer Diagnostics by Type in 2015
1.2.2 Next Generation Sequencing
1.2.3 qPCR & Multiplexing
1.2.4 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
1.2.5 Protein Microarrays
1.2.6 DNA Microarrays
1.3 Next Generation Cancer Diagnostics Segment by Application
1.3.1 Next Generation Cancer Diagnostics Consumption Market Share by Application in 2015
1.3.2 Lung Cancer
1.3.3 Breast Cancer
1.3.4 Colorectal Cancer
1.3.5 Cervical Cancer
1.3.6 Others
1.4 Next Generation Cancer Diagnostics Market by Region
1.4.1 North America Status and Prospect (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 China Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Next Generation Cancer Diagnostics (2012-2022)

2 Global Next Generation Cancer Diagnostics Market Competition by Manufacturers
2.1 Global Next Generation Cancer Diagnostics Production and Share by Manufacturers (2015 and 2016)
2.2 Global Next Generation Cancer Diagnostics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Next Generation Cancer Diagnostics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Next Generation Cancer Diagnostics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Next Generation Cancer Diagnostics Market Competitive Situation and Trends
2.5.1 Next Generation Cancer Diagnostics Market Concentration Rate
2.5.2 Next Generation Cancer Diagnostics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Next Generation Cancer Diagnostics Production, Revenue (Value) by Region (2012-2017)
3.1 Global Next Generation Cancer Diagnostics Production and Market Share by Region (2012-2017)
3.2 Global Next Generation Cancer Diagnostics Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Next Generation Cancer Diagnostics Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Next Generation Cancer Diagnostics Consumption by Regions (2012-2017)
4.2 North America Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)
4.4 China Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)
4.7 India Next Generation Cancer Diagnostics Production, Consumption, Export, Import (2012-2017)

5 Global Next Generation Cancer Diagnostics Production, Revenue (Value), Price Trend by Type
5.1 Global Next Generation Cancer Diagnostics Production and Market Share by Type (2012-2017)
5.2 Global Next Generation Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
5.3 Global Next Generation Cancer Diagnostics Price by Type (2012-2017)
5.4 Global Next Generation Cancer Diagnostics Production Growth by Type (2012-2017)

6 Global Next Generation Cancer Diagnostics Market Analysis by Application
6.1 Global Next Generation Cancer Diagnostics Consumption and Market Share by Application (2012-2017)
6.2 Global Next Generation Cancer Diagnostics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Next Generation Cancer Diagnostics Manufacturers Profiles/Analysis
7.1 Cepheid
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.1.2.1 Next Generation Sequencing
7.1.2.2 qPCR & Multiplexing
7.1.3 Cepheid Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Koninklijke Philips N.V
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.2.2.1 Next Generation Sequencing
7.2.2.2 qPCR & Multiplexing
7.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 F. Hoffmann-La Roche Ltd
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.3.2.1 Next Generation Sequencing
7.3.2.2 qPCR & Multiplexing
7.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Qiagen
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.4.2.1 Next Generation Sequencing
7.4.2.2 qPCR & Multiplexing
7.4.3 Qiagen Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Novartis AG
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.5.2.1 Next Generation Sequencing
7.5.2.2 qPCR & Multiplexing
7.5.3 Novartis AG Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Abbott
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.6.2.1 Next Generation Sequencing
7.6.2.2 qPCR & Multiplexing
7.6.3 Abbott Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Thermo Fisher Scientific
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.7.2.1 Next Generation Sequencing
7.7.2.2 qPCR & Multiplexing
7.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Opko Health
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.8.2.1 Next Generation Sequencing
7.8.2.2 qPCR & Multiplexing
7.8.3 Opko Health Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Myriad Genetics
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.9.2.1 Next Generation Sequencing
7.9.2.2 qPCR & Multiplexing
7.9.3 Myriad Genetics Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Agilent Technologies
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Next Generation Cancer Diagnostics Product Type, Application and Specification
7.10.2.1 Next Generation Sequencing
7.10.2.2 qPCR & Multiplexing
7.10.3 Agilent Technologies Next Generation Cancer Diagnostics Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 GE Healthcare
7.12 PerkinElmer
7.13 Genomic Health
7.14 Illumina
7.15 Hologic
7.16 Almac Group
7.17 Janssen Global Services
7.18 Sysmex Corporation

8 Next Generation Cancer Diagnostics Manufacturing Cost Analysis
8.1 Next Generation Cancer Diagnostics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Next Generation Cancer Diagnostics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Next Generation Cancer Diagnostics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Next Generation Cancer Diagnostics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Next Generation Cancer Diagnostics Market Forecast (2017-2022)
12.1 Global Next Generation Cancer Diagnostics Production, Revenue and Price Forecast (2017-2022)
12.1.1 Global Next Generation Cancer Diagnostics Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Next Generation Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Next Generation Cancer Diagnostics Price and Trend Forecast (2017-2022)
12.2 Global Next Generation Cancer Diagnostics Production, Consumption , Import and Export Forecast by Regions (2017-2022)
12.2.1 North America Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Next Generation Cancer Diagnostics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Next Generation Cancer Diagnostics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Next Generation Cancer Diagnostics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

To Purchase this premium Report With Complete TOC at http://globalqyresearch.com/checkout-form/0/163736

About Us:

Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 32392407

Email: sales@globalqyresearch.com

Follow us:https://www.linkedin.com/company/global-qy-research

Twitter: https://twitter.com/gqyresearch